The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

Published:2010-11-04 Issue:1 Volume:18 Page:85-95
ISSN:1351-0088
Container-title:Endocrine Related Cancer
language:en
Short-container-title:Endocrine Related Cancer

Author:

Leskela S.,Leandro-Garcia L. J.,Mendiola M.,Barriuso J.,Inglada-Perez L.,Munoz I.,Martinez-Delgado B.,Redondo A.,de Santiago J.,Robledo M.,Hardisson D.,Rodriguez-Antona C.

Publisher

Bioscientifica

Subject

Cancer Research,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiRNA Dysregulation in Brain Injury: An In Silico Study to Clarify the Role of a MiRNA Set;Current Neuropharmacology;2024-08-08

2. Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells;PLOS ONE;2024-07-19

3. An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection;Heliyon;2024-05

4. Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool;Frontiers in Molecular Biosciences;2024-04-16

5. MiRNAs related in signaling pathways of women’s reproductive diseases: an overview;Molecular Biology Reports;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP